Literature DB >> 3752709

Increased cathepsin B-like activity in alveolar macrophages and bronchoalveolar lavage fluid from smokers.

J C Chang, M Lesser, O H Yoo, M Orlowski.   

Abstract

Cathepsin B-like activity was determined in alveolar macrophages (AM) and cell-free bronchoalveolar lavage fluid (BALF) obtained from volunteers who were current cigarette smokers and compared with that found in lifetime nonsmokers. Enzyme activity was determined with benzyloxycarbonyl-Leu-Leu-Arg-2-naphthylamide as the substrate. Specific activity of the enzyme was more than twice as high in AM from smokers than in cells from nonsmokers (35,600 +/- 2,250 versus 16,000 +/- 860; p less than 0.001) and about 10 times as high in BALF from smokers than in that from nonsmokers (3,060 +/- 380 versus 300 +/- 25; p less than 0.001). Because cathepsin B is capable of degrading structural lung proteins and inactivating alpha-1-proteinase inhibitor, and the elastinolytic activity of AM may be mediated through cysteine proteinases such as cathepsin B, the finding of high concentrations of an enzyme with cathepsin B-like activity in AM and BALF from smokers suggests the need to explore the role of the enzyme in structural lung damage associated with cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3752709     DOI: 10.1164/arrd.1986.134.3.538

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

1.  The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor.

Authors:  R W Mason; D Wilcox; P Wikstrom; E N Shaw
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

2.  A catalytically active high-Mr form of human cathepsin B from sputum.

Authors:  D J Buttle; B C Bonner; D Burnett; A J Barrett
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

3.  Complete degradation of type X collagen requires the combined action of interstitial collagenase and osteoclast-derived cathepsin-B.

Authors:  U I Sires; T M Schmid; C J Fliszar; Z Q Wang; S L Gluck; H G Welgus
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

4.  Contribution of cathepsin B-dependent Nlrp3 inflammasome activation to nicotine-induced endothelial barrier dysfunction.

Authors:  Yang Zhang; Yang Chen; Youzhi Zhang; Pin-Lan Li; Xiang Li
Journal:  Eur J Pharmacol       Date:  2019-11-13       Impact factor: 4.432

5.  An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines.

Authors:  A R Nusrat; H A Chapman
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

6.  The identification of the major excreted protein (MEP) from a transformed mouse fibroblast cell line as a catalytically active precursor form of cathepsin L.

Authors:  R W Mason; S Gal; M M Gottesman
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

7.  Biochemical quantitation and histochemical localization of cathepsin B, dipeptidyl peptidases I and II, and acid phosphatase in pulmonary granulomatosis and fibrosis in rats.

Authors:  S H Randell; P L Sannes
Journal:  Inflammation       Date:  1988-02       Impact factor: 4.092

8.  Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking.

Authors:  A Schweiger; A Staib; B Werle; M Krasovec; T T Lah; W Ebert; V Turk; J Kos
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.